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Highlights 
 Formalin fixation with paraffin embedment is most widely used for tissue fixation 
 Formalin fixation differently affects various biomolecules 
 Biomarker discovery form FFPE samples is the Holy Grail of molecular diagnostics 
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Abstract 
More than a century ago in 1893, a revolutionary idea about fixing biological tissue 
specimens was introduced by Ferdinand Blum, a German physician. Since then, a plethora of 
fixation methods have been investigated and used. Formalin fixation with paraffin embedment 
became the most widely used types of fixation and preservation method, due to its proper 
architectural conservation of tissue structures and cellular shape. The huge collection of 
formalin-fixed, paraffin-embedded (FFPE) sample archives worldwide holds a large amount 
of unearthed information about diseases that could be the Holy Grail in contemporary 
biomarker research utilizing analytical omics based molecular diagnostics. The aim of this 
review is to critically evaluate the omics options for FFPE tissue sample analysis in the 
molecular diagnostics field. 
 
Abbreviations 
AMeX: acetone-methylbenzoate-xylene; CE: capillary electrophoresis; FFPE: formalin-
fixed, paraffin-embedded; HOPE: Hepes-glutamic acid buffer-mediated organic solvent 
protection effect; LC: liquid chromatography; MALDI: matrix-assisted laser 
desorption/ionization; MS: mass spectrometry; MSI: mass spectrometry imaging; MW: 
microwave; NBF: neutrally buffered formalin; PCR: polymerase chain reaction; SDS: 
sodium dodecyl sulfate;  
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Introduction 
Formalin-fixed, paraffin-embedded (FFPE) tissue specimens represent an extremely valuable 
sample source for prospective and retrospective biomedical and biopharmaceutical studies, 
therefore, could be the Holy Grail for analytical omics based molecular diagnostics. FFPE 
samples are banked in hospital archives worldwide for decades, thus appropriate number of 
samples can be quickly cherry-picked for specific retrospective studies with the great 
advantage of having the associated clinical history of the patients. This largely unexploited 
resource represents an extensive repository of tissue material with clinical follow-up 
information, providing a valuable resource for translational clinical research, especially with 
the use of modern analytical omics tools at the molecular level. Therefore, the use of FFPE 
samples in biomarker discovery could be of high interest.  
There is an increasing need for validated biomarkers in the diagnostics field to stratify 
patients for targeted therapies and to monitor therapeutic responses for a wide spectrum of 
diseases. Blood or tissue specimens are frequently used in the omics field to discover new 
biomarkers. FFPE tissue specimens can represent a valuable alternative in the field of 
molecular diagnostics [1] as they are routinely prepared for pathological studies [2]. 
Moreover, the archived material is kept for decades in most countries, and usually 
accompanied with the clinical outcome information [3]. 
In the past decade, many molecular level FFPE studies have been reported, mainly covering 
the following three categories: 1) studies investigating FFPE DNA and protein extraction 
methods (this latter is also referred to as antigen retrieval), very often accompanied with fresh 
frozen (fr/fr) versus FFPE tissue comparison [4, 5]; 2) articles determining the suitability of 
FFPE specimens in biomarker research [6]; and 3) studies looking for the influence of 
preanalytical factors such as fixation time and protocol or archival time [7]. This last one is 
important because tissue preparation parameters may result in some degradation of the 
sample, e.g., differences were found in rRNA patterns between 4 ºC and 37 ºC incubation, and 
the pattern almost completely disappeared after 12 hours incubation at 37 ºC [8]. 
This review compares the most frequently used methods of FFPE tissue preparation, analysis 
and their potential utilization in molecular diagnostics. Many studies have been published on 
the recovery of biomolecules from FFPE tissue samples with the goal of biomarker discovery 
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via analytical omics. One of the major challenges was to develop special protocols to recover 
the biomolecules of interest in their intact or close-to intact forms. The next challenge will be 
to reveal the biological information they possess for utilization in the every-day clinical 
practice, e.g., to detect diseases in early stages.  
2. Tissue fixation and embedding techniques 
2.1 Formaldehyde fixation 
Histology is an essential discipline since Rudolph Virchow has established the principal 
values in his pioneering work [9]. Formaldehyde as a chemical was first reported in 1859 by 
Butlerov, however, the practical method of its synthesis was invented only 10 years later. Due 
to its disinfectant properties, formalin was proposed for medical applications by the German 
physician Ferdinand Blum in 1893 [10]. During his work towards the end of the 19th century, 
Blum realized that tissues treated with formalin hardened, even more than with other 
commonly used agents at that time and summarized the results of his findings in 1910 [11]. 
Based on his reports, contemporary histologists confirmed the unequally advantageous 
properties of formalin as a fixative, preserving tissues without significant shrinkage or 
distortion, in contrast to alcohol-based reagents. Moreover, classic staining procedures with 
hematoxylin and eosin dyes were compatible with this fixation method. Since then, formalin 
fixation procedure has become the gold standard for pathological tissue preservation. Other 
advantages of this conservation method were good architectural preservation of tissue 
structures and cellular shape stabilization. [12].  
From chemical point of view, formaldehyde reacts with the free amino groups of proteins and 
peptides during the fixation process, via the formation of methylol groups as shown in Figure 
1. The reaction with formaldehyde consists of two steps. First, when the primary amine 
(nucleophilic group; R) and the aldehyde produce a hydroxymethyl form. After losing a water 
molecule, a Schiff base is formed. In the second step, during the stabilization, other proteins 
are involved in the reaction and linked with methylene bridges. It is a stable crosslink between 
amino acids such as arginine, glutamine, tryptophan, histidine, asparagine, and tyrosine in the 
form of methylene bridges within or in between proteins and their subunits [13]. Formalin 
fixative solutions are usually prepared by dissolving 37 – 40% w/w formaldehyde in water, 
containing 10-15% methanol as stabilizer. Tissues are routinely fixed for 24–48 hours in 10% 
v/v solution of formalin (3.7 – 4.0% formaldehyde, buffered with phosphate to pH 7.0). 
Fixation in this way yields samples, which can be stored at ambient condition for decades. 
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Combined with paraffin embedding (described below), the resulting formalin-fixed, paraffin-
embedded samples are routinely used in histological and histopathological laboratories. FFPE 
samples can be stored long-term at room temperature that is easier and simpler that of dealing 
with the storage of fresh/frozen tissues, which require -80 °C or even in liquid Nitrogen in 
some instances. Figure 2 shows the main steps of the formalin fixation and paraffin 
embedding process. The first step is sampling, which is usually done by a surgeon. The 
sample then either gets frozen or fixed immediately. Fixation takes place in a 10% buffered 
formalin solution for 24 to 48 hours at room temperature. If samples are spaded, penetration 
of formalin into the tissue is more sufficient. The next step is paraffin embedding that requires 
dehydration of the sample by washing twice with ethanol and xylene, respectively. The 
dehydrated sample is embedded in melted paraffin and allowed to solidify at room 
temperature. The formalin-fixed, paraffin-embedded block is then cut into 3-5 µm sections for 
pathologic and molecular diagnostic investigation. Research groups from all around the world 
have recently started evaluating the huge archival FFPE sample collection from molecular 
diagnostics point of view because of their clinical-pathological significance [13].  
2.2 Tissue fixation by microwave irradiation 
Tissue fixation can also be accomplished by alternative techniques to alleviate some of the 
non-desirable effects of the formaldehyde, e.g., the direct reaction with nucleotides, which 
could result in degradation of the nuclear material. One of the substitute methods for tissue 
fixation is microwave irradiation (MW) with a frequency range between 300 MHz and 300 
GHz, first reported by Mayers [14]. He described that direct exposure to MW irradiation 
resulted in satisfactory fixation of mouse and human postmortem tissues without the addition 
of formalin. MW fixation depends on the chemical environment surrounding the specimen 
during the irradiation process, the duration of the microwave exposure, and the sequence of 
microwave irradiation (before or after the chemical fixation) as well as chemicals present such 
as formaldehyde, methanol or glutaraldehyde. As of today, five major MW assisted fixation 
methods are used: 1) For stabilization, the samples are irradiated in situ or in a physiological 
salt solution to avoid structural degradation otherwise might happen with the use of a 
chemical fixatives. 2) Fast or ultrafast primary MW combined with chemical fixation in 
which specimens are exposed to MW irradiation in a formaldehyde containing chemical 
environment for very short time periods, ranging from milliseconds to seconds. 3) MW 
irradiation followed by chemical fixation to improve fixation uniformity. 4) Primary chemical 
fixation followed by MW irradiation to ease the penetration of the fixatives inside the sample. 
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5) MW irradiation applied together with freezing to further promote the preservation of the 
samples [15]. While, the great advantage of microwave stabilization is to avoid or minimize 
the involvement of chemicals, it has got some disadvantages including constriction, 
sponginess of tissues, and collapse of red blood cells [16]. On the other hand, microwave 
irradiation can increase diffusion of the fixation reagents deep into the tissue and accelerate 
the chemical crosslinking process. Primary microwave irradiation is an attractive alternative 
fixation method for ultrastructural and genetic studies because it provides easy access for the 
cross-linking reagent to penetrate the tissue. However, using MW irradiation on tissues 
previously fixed in formalin often results in poor outcome since the surface of the tissue fixes 
so quickly that it apparently restrains further diffusion of the fixative into the inner parts of 
the sample. Therefore, a combined procedure is recommended, which starts by formalin 
fixation of the tissue blocks for a few hours at room temperature, followed by microwave 
irradiation for 1 to 2 minutes at 55°C [17]. The speed by which microwaves can help to 
complete fixation of both large and small biopsy specimens is a major advantage, thus MW 
fixation considerably reduces processing time before paraffin embedding [18, 19]. 
2.3 Other fixatives  
In some instances, the use of alternative chemical fixatives overcomes the possible problems 
of formaldehyde treatment mentioned earlier and could be better for the special task in hand, 
e.g., preservation of nucleic acids and proteins. Similar to formaldehyde, glutaraldehyde also 
acts as a cross-linking agent for tissue sample fixation as was first introduced by Sabatini et 
al. [20]. Glutaric dialdehyde, the aqueous solution of glutaraldehyde contains 70% hemiacetal, 
16% monohydrate, 9% dihydrate and ∼4% free aldehyde. Glutaraldehyde preferably reacts 
with nucleic acids and the ε-amino groups of amino acids through its aldehyde functional 
groups. Douglas et al. [21] reported that high-molecular weight DNA can be better preserved 
by 1% glutaraldehyde at pH 7.0 than in 10% formalin. It is important to note that the diffusion 
rate of 4% glutaraldehyde (at 4°C) is approximately half that of for the same concentration 
formaldehyde solution. Albeit, glutaraldehyde is widely used as a fixative for standard 
electron microscopy, the need for periodic purification to maintain the functional aldehyde 
levels and the slower penetration rate have greatly limited its use as pathological/ biological 
fixative. 
Genipin (C11H14O5), extracted from Gardenia jasminoides is an aglycon and acts as a natural 
cross-linker, which can spontaneously react with amino acids. This fixative is excellent for 
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cross-linking collagen, gelatin, and chitosan. It has low acute toxicity (LD50 i.v. 382 mg/kg in 
mice), therefore, much less toxic than many other commonly used synthetic cross-linking 
reagents. It was reported, however, that after genipin fixation, the resistance of the tissue 
against collagenase degradation significantly increased. The effect of genipin fixation on 
tissue nucleic acids is not known [22]. 
Methanol and ethanol was first used as a fixative by Camillo Golgi [23]. For nucleic acid 
fixation it is recommended to use alcoholic reagents, which are non-crosslinking [24, 25]. 
Prior to use of nucleases, nucleic acids are precipitated from the alcohol in the presence of 
salts, however, the procedure tends to cause shrinkage, thereby making the sample less 
suitable for morphological studies [21]. 100% methanol and ethanol are perceived as adequate 
fixatives to prevent high-molecular weight DNA and RNA from degradation. On one hand 
methanol, ethanol and acetone preserved relatively high molecular weight DNA (≈ 440 000 
Da) equally well, compared to formalin. On the other hand, histological analyses revealed that 
regional tissue shrinkage differences occurred in ethanol and acetone fixed specimens, 
compared to methanol-fixed ones [24, 25].  
Since no particular fixative is adequate to preserve all types of tissue samples for various 
applications, mixtures of several fixatives have also been attempted to alleviate this handicap. 
One common reagent is the mixture of 60% ethanol, 30% chloroform and 10% glacial acetic 
acid, known as Carnoy’s fixative, that proved to offer optimal preservation of tissue nucleic 
acids [26]. In comparison to neutrally buffered formalin fixation (NBF), RNA was easily 
extractable from Carnoy’s-fixed tissues and only some slight degradation was observed in the 
high-molecular weight RNA range [25]. Application of post-fixation formaldehyde vapor 
reduced cellular RNA loss from Carnoy’s-fixed tissues, which was important before in situ 
hybridization (ISH) [19]. By all means, alcohol-based fixatives showed great efficiency to 
preserve the molecular integrity of nucleic acids in tissue samples [19, 27]. 
Another frequently used fixative mixture is 60% methanol, 30% chloroform and 10% glacial 
acetic acid, called as methacarn. Replacing ethanol with methanol resulted in an outstanding 
alternative to preserve RNA in tissue samples. Methacarn and Carnoy’s fixatives were 
introduced by Puchtler et al. [28, 29]. Using cultured cell lines and rodent tissues, Shibutani et 
al. [30] have demonstrated that the integrity of the extracted total RNA content, and also the 
efficiency of the extraction from methacarn-fixed tissues, produced identical results to 
unfixed frozen cells and tissue samples. Genomic DNA contaminant concentration was very 
AC
CE
PT
ED
 M
AN
US
CR
IPT
8 
 
low, and 300-700 base fragment long species of both low copy number RNA and abundant 
mRNA were amplified successfully from methacarn-fixed tissues [30]. It has also been 
suggested that methacarn fixation induced ribosomal protein precipitation, thereby reduced 
endogenous RNase activity. Methacarn fixation was also better than NBF in preserving 
antigen immunoreactivity requiring no antigen retrieval, therefore, recommended for 
prospective immunohistochemical tissue studies [31]. 
Acetone is widely used as a fixative in the so called AMeX (acetone-methylbenzoate-xylene) 
technique [32]. The procedure requires overnight tissue fixation in acetone at −20 °C, then a 
xylene and methylbenzoate wash prior to paraffin embedding to maintain the morphology of 
the sample and also to preserve the immunoreactivity of unstable proteins. AMeX-treated 
tissues provided intact high-molecular weight DNA in good quality, ideal for molecular 
diagnostic analysis. Moreover, signals of c-myc mRNA and albumin mRNA were comparable 
to the ones from fresh/frozen tissues. Dot-blot hybridization-based detection was also 
successfully carried out from isolated RNA of previously AMeX-fixed tissues [33]. 
The HOPE method (Hepes-glutamic acid buffer-mediated organic solvent protection effect) 
involves incubation of fresh tissues in a protecting solution that contains mixtures of amino 
acids with pH ranging from 5.8 to 6.4 [34]. Dehydration was accomplished by incubation in 
acetone between 0 and 4°C. The protective solution accelerated dehydration by enhancing the 
infusion of acetone. As the last step, the specimens were placed into paraffin. This new 
fixation method was suitable for full-scale pathological analysis, consequently adequate for 
both immunohistochemistry and molecular pathology. HOPE-fixed sections tend to show 
formalin fixation type morphology and preserve proteins and antigenic structures for 
differential analysis by immunohistochemical and/or enzyme histochemical techniques. 
HOPE-fixed specimens provided eligible quality RNA and DNA, even after 5 years of 
storage. The DNA and RNA in those samples were subject to polymerase chain reaction 
(PCR), reverse transcription polymerase chain reaction (RT-PCR) analysis and fluorescence 
in situ hybridization (FISH). The noncross-linking feature and the high amount of recovered 
nucleic acids clearly showed the valuable alternative HOPE fixation offered [34]. 
Other fixation additives like mercury (II) chloride (Helly’s, Zenker’s, Ridley’s solutions or 
B5), picric acid (Bouin’s solution) and tannic acid all improved tissue penetration. Metal salt 
solutions, like zinc sulfate or phenol containing reagents (they have less toxicity) increased 
protein precipitation efficiency. Some of the aforementioned preservatives have been proved 
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to be valid alternatives in various immunohistochemical studies, but only limited data is 
available about their use as nucleic acid preserving agents [27]. Table 1 summarizes the most 
frequently used fixatives for tissue preservation.  
2.4 Paraffin embedding 
Formalin or other fixation techniques in combination with paraffin embedding retains the 
cellular details and morphology of tissue samples. Therefore, formalin-fixation, paraffin 
embedding quickly became the standard preservation method for diagnostic pathology. In 
clinical practice, biopsy samples usually treated with formalin as described above then further 
prepared for paraffin embedding by washing with ethanol and xylene to ensure the removal of 
all water content. Upon full dehydration, melted paraffin is added to the dry formalin fixed 
tissue samples and let solidify at room temperature [35]. Pathology departments routinely 
archive large quantities of FFPE specimens worldwide, since long-term storage of frozen 
tissues demands extra low temperatures, thus keeping them for long term is more complicated 
than the storage of FFPE blocks.  
3 Analytical Omics 
3.1 Genomics  
Formalin fixation parameters of time and temperature are critical in maintaining nucleic acid 
(DNA and RNA) integrity [36], but fortunately only small fragments of mRNAs are required 
to reconstruct an expression profile of a given gene. Degradation might not always be 
distinctly observable when quantifying mRNA, but low expression profile genes with short 
half-life might be significantly affected [37], thus should be investigated with greater scrutiny.  
DNA isolated from FFPE blocks, even if highly fragmented are still useable for PCR 
amplification of shorter products up to 250 bp in length [38]. In addition, partially fragmented 
DNA was applicable for downstream analysis by sequence-specific oligonucleotide (SSO) 
probe procedures in combination with PCR. Ribeiro-Silva et al. found that RNA in FFPE 
samples may degrade over time into smaller fragments, indicated by the much lower RNA 
quality indicators than in fresh / frozen tissues, however, could still be successfully used in 
gene expression analysis [39]. DNA and miRNA extracted from FFPE blocks have currently 
reached levels that allow their application as essential and primary approaches in the search 
for new genomic disease markers [40].  
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DNA is a very stable type of cellular macromolecule however, it often loses the quality 
needed for high throughput analysis methods like microarrays or sequencing. Thus, special 
extraction methods have been developed to alleviate this issue [41]. RNA, on the other hand, 
is prone to cross-linking to proteins during the formalin fixation process. To offset the 
problems in isolation, amplification, and quantification Specht et al. [42] introduced a 
method, which combined laser-capture microdissection (LCM) and quantitative reverse 
transcription polymerase chain reaction (QRT-PCR), using proteinase-K for digestion and 
extraction of RNA. This has made quantitative gene expression analysis possible from 
archived tissue banks. Several publications reported about the use of FFPE tissue samples in 
RNA analysis [43-56] 
FFPE based gene expression analysis panels are now in the routine diagnosis such as HTG 
EdgeSeq Oncology Biomarker Panel (https://www.htgmolecular.com), High Pure RNA 
Paraffin Kit (https://lifescience.roche.com), Oncotype DX test 
(http://www.genomichealth.com), Breast Cancer Index test (http://www.biotheranostics.com), 
EndoPredict test (https://myriad.com), MammaPrint test (http://www.agendia.com) or 
Prosigna Breast Cancer Prognostic Gene Signature Assay (https://www.nanostring.com).  
3.2 Proteomics 
Proteomics profiling of FFPE archival tissues holds the promise to find potential disease 
biomarkers at the protein level for diagnostic and therapeutic follow-up. However, this option 
has not been realized yet, due to such challenges as limitations of high sensitivity analytical 
instrumentations, lack of efficient antigen retrieval methods, or even restricted sample 
accessibility [13].  
Formaldehyde fixation affects proteins at different levels. The first is in their primary 
structure through amino acid modification including lysine, arginine, serine, tyrosine, 
asparagine, histidine and glutamine [57]. The principal cross-linking between the side chain 
amino groups of the above mentioned amino acids are manifested as methylene bridges. 
Cross-linking can also occur between the aminomethylol groups and phenol, indole and 
imidazole side chains via Mannich reaction. Cross-linking modifies the α-helixes and β-sheets 
of the secondary protein structures, also causing alterations in their tertiary structures, even 
link multiple proteins. These changes may hinder protein identification when trying to match 
with in silico databases after mass spectrometry (MS) analysis [13].  
AC
CE
PT
ED
 M
AN
US
CR
IPT
11 
 
Recent attempts aimed investigating protein identification options from FFPE blocks after 
long-term storage. The results showed that low abundance proteins might suffer an archival 
effect suggested by the less than ten spectral counts in mass spectrometry. These proteins 
were difficult to retrieve from tissue blocks older than 10 years [58]. Magdeldin et al. [13] 
investigated the effect of archival time by K-means cluster analysis of FFPE tissue proteomes 
from samples stored for 9 to 21 years. Their findings revealed that, at the level of protein and 
distinct peptide identification, more peptides were identifiable in the blocks that were stored 
for 9 years compared to 21 years. 
Proteins isolated from FFPE blocks have been successfully used in Western blot analysis, 
reverse-phase protein arrays, and surface-enhanced laser desorption/ionization (SELDI) time-
of-flight MS [59]. The reverse phase protein array (RPPA) method is similar in fashion and 
structure to Western-blot analysis because of the use of target specific primary antibodies and 
fluorescently labeled secondary antibodies. Different proteins can be analyzed by 
simultaneously comparing their relative fluorescence levels [60].  
Ambiguous results were frequently obtained in global proteome analysis of FFPE specimens 
due to the failure of matching the experimentally found peptides to those in the existing 
databases, such as EBI (European Bioinformatics Institute), Proteome Analysis, InterPro and 
CluSTr [61], just to list the most important ones. The possibility of correct peptide 
identification depends on the degree of modification and cross-linking caused by the fixation 
process, thus, can be categorized accordingly, i.e., high, moderate or low probability for 
successful identification. Peptides in the first group are mainly non-modified ones and usually 
match protein database entries. Peptides with a moderate likelihood to be properly identified 
are non-crosslinked peptides with known modifications. The identification of this second 
peptide group mainly depends on the database search engine used and the precise knowledge 
about the modifications occurred during formalin fixation. The last group represents formalin 
cross-linked peptides, which may also be modified by endopeptidase digestion. These 
peptides have low chance to be correctly identified and the modifications caused by the 
fixation may also lead to shifts in their physicochemical properties from native forms, thus 
identification of this group of peptides is very challenging [13].  
Effective proteomic analysis of FFPE samples relies on proper extraction, denaturation, and 
digestion with extensive knowledge about all possible peptide modification(s). By applying 
proper antigen retrieval techniques, Shi and associates successfully applied 
immunohistochemistry (IHC) on FFPE samples [62]. As a matter of fact, IHC on FFPE 
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blocks became a widely used procedure in routine diagnostic pathology. Recent technical 
advances in the field of molecular biotechnology made possible the extraction of 
glycoproteins from FFPE blocks for downstream analysis. Near the end of the last century, 
one of the pioneers in this extraction field, Ikeda et al. [63] studied the effect of several 
special buffers and temperatures and found that combining lysis buffers, e.g., RIPA (radio 
immunoprecipitation assay buffer) with high concentration sodium dodecyl sulfate (SDS) at 
appropriate temperatures resulted in efficient protein recovery. After its introduction, several 
groups attempted to improve the method by applying other buffer systems to increase the 
extraction yield. Tris-HCl was the general starting buffer at different pHs, mostly containing a 
number of chaotropes and detergents. The generally utilized extraction solutions of 50 mM 
Tris-HCl at pH 7 [4] and 20 mM Tris-HCl at pH 9 have been used with 2% SDS in 
combination with heat-induced retrieval conditions (20 min at 100ºC, then 120 min at 60ºC) 
[64]. Reducing agents of beta-mercaptoethanol [65] or dithiothreitol (DTT) were reportedly 
added to these buffers for antigen retrieval from skeletal muscle or liver samples [66, 67], as 
well as heart tissues [68] along with the use of octylglucoside detergent. Chaotropic agents 
like guanidin-HCl [69] were also used for protein retrieval from FFPE tissues [70]. RIPA 
buffer in combination with high concentration sodium chloride, Triton X-100, sodium 
deoxycholate, phenylmethylsulfonyl fluoride, aprotinin, leupeptin (addition of protease 
inhibitors is optional; aprotinin inhibits serine proteases, such as trypsin, chymotrypsin, 
plasmin, trypsinogen, urokinase, and kallikrein; leupeptin inhibits both serine and cysteine 
proteases, such as calpain, trypsin, papain, and cathepsin B) and SDS was used on colorectal 
carcinoma [63], lymphoma [71], and prostate cancer FFPE specimens [72]. Addition of 
organic solvents were also attempted at different concentrations, e.g., 30% acetonitrile was 
applied to pancreatic [73] and colon cancer tissues [74], while 50% trifluoroethanol was 
tested in lung tissue processing [75].  
Commercial reagents are also available for FFPE tissue processing, like the acid-deteriorating 
detergent RapiGest [76], Liquid Tissue MS protein Prep kit [77, 78], Qproteome FFPE tissue 
kit [79], NDME-U [80], and the FFPE Protein Extraction Solution [81]. All of these reagent 
kits can be applied with a digestion step accomplished on various molecular filtration units 
[81]. Such Filter Aided Sample Preparation (FASP) procedure was elaborated by Mann and 
coworkers [82] to recover proteins from FFPE tissues using complex lysis solutions 
composed of detergents (e.g., SDS), chaotropes (e.g., urea), denaturing solutions (e.g., DTT) 
and alkylating agents (e.g., iodoacetamide). The filter-based approach was particularly 
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efficient in removing or changing buffers and rinsing the samples; however, it was important 
to ensure that the treatments did not damage the filter. Subsequently, protein digestion could 
be performed directly on the filter to recover the tryptic peptides, which were then subject to 
analysis after desalting [83]. This procedure was apparently very efficient in proteomics 
studies of microdissected tissue samples as well for subsequent LC-MS/MS analysis that 
identified up to 10,000 proteins [84]. Among these studies, researchers tried to evaluate the 
efficiencies of the extraction procedures on FFPE tissues in comparison to fr/fr tissue 
samples. Generally, analysis of fr/fr tissues may identify a higher number of proteins 
compared to FFPE tissues [85], albeit, some studies reported better protein identification from 
FFPE tissues [76, 86, 87]. These comparisons were of vital importance in finding the adequate 
sample preparation methods for efficient of FFPE specimen analysis [81].   
Currently available tools for tissue sampling and analysis are extremely diverse and allow 
researchers to address many questions using the most relevant approaches. Matrix-assisted 
laser desorption / ionization (MALDI) MS imaging, e.g., allows mapping of hundreds of 
compounds on a tissue section in a differential manner, thus represents strong illustration of 
the synergy between ‘‘classical’’ and ‘‘molecular’’ histology [81]. MALDI imaging mass 
spectrometry with ultra-highspeed matrix-assisted laser desorption/ionization time-of-flight 
(MALDI-TOF) and high mass resolution matrix-assisted laser desorption/ionization Fourier 
transform ion cyclotron resonance imaging mass spectrometry (MALDI FTICR IMS) 
platforms are powerful tools to visualize proteins in fixed tissues. Spraggins et al. [88] have 
used high spatial resolution MALDI-TOF technique to obtain protein images of rat brain 
tissues and cystic fibrosis lung tissues with image acquisition at rates of >25 pixels/s. 
Structures as small as 50 μm were spatially resolved and the proteins associated with the host 
immune response were identified in cystic fibrotic lung tissue.  
Yin et al. [89] investigated different stage colorectal cancer FFPE tissues by mass 
spectrometry. As a result of their study, they provided large scale systematic quantification for 
the differentially expressed proteins during cancer development from early stage to stage IIIC. 
Approximately two-thirds of the detected proteins were quantified. Label free quantification 
and iTRAQ (using isobaric tag for relative and absolute quantitation) was also reported [90]. 
3.3 Glycomics 
Carbohydrates play vital roles in biological processes such as cell–cell and cell–extra cellular 
matrix interactions, protein degradation, inflammation, and activation of the immune 
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system. They participate in motility and adhesion, intracellular signaling, and also control 
protein folding, stabilize the conformation of proteins, modify immunological properties and 
act as cell surface receptors for lectins, antibodies and toxins [91]. Any alterations in these 
functions (e.g., normal cells transforming into malignant ones) can appear as changes in the 
cell surface glycan profile in many diseases [92]. Glycosylation changes have been shown in 
cancer, cardiovascular, autoimmune and neurodegenerative diseases [93], just to list a few 
important ones. Therefore, specific structural changes in glycans may serve as biomarkers 
[94], and the type of the change can be correlated to the disease [95]. 
The major glycoconjugate classes in vertebrates are glycoproteins, proteoglycans, 
glycolipids, glycosaminoglycans and O-GlcNAcylation. Most glycoconjugates are located in 
the cell surface membranes. Glycoproteins have the two major types based on the way their 
sugar moieties bound to the polypeptide chain: asparagine (N-) and serine/threonin (O-) 
linked glycans.. Around 1% of the human genome participates in the biosynthesis of glycans 
[96], resulting in one of the most complex co- and post-translational modifications of proteins. 
The great variability in glycan structures is contributing the ability to fine-tune the chemical 
and biological properties of glycoproteins. For N-linked glycosylation, after the initial co-
translational attachment of the GlcNAc2Man9Glc3 structure during the synthesis of the 
polypeptide backbone, the final processing of carbohydrates occurs in the Golgi apparatus and 
the endoplasmic reticulum, but in some instances may also in the cytoplasm and nucleus [97]. 
All asparagine linked glycans share a common paucimannose core structure of Manα1–
6(Manα1–3)Manβ1–4GlcNAcβ1–4GlcNAcβ1 at an Asn-X-Ser/Thr consensus sequence (X 
cannot be Ser, Thr or Pro). N-linked glycans can be classified into three categories: (1) high 
mannose type, in which only mannose residues are attached to the core; (2) complex type, in 
which all sugar types are attached but mannose; and (3) hybrid type, in which only mannose 
residues are attached to the Manα1–6 arm of the core and one or two complex type antennas 
are to the Manα1–3 arm. O-linked glycans are attached to serine or threonine residues with 
currently known 8 core structures [97]. 
Histochemical staining using lectins is one of the common methods to analyze the glycan 
moieties of FFPE tissue sections. Concanavalin A (ConA) and Aleuria Aurantia Lectin (AAL) 
are the two most frequently used lectins in histostaining to detect oligomannose and 
fucosylated glycans, respectively [98]. Unfortunately, lectin affinity-based methods cannot 
reveal enough structural information about the epitopes. For instance, ConA can bind to both 
terminal and internal α-mannoses [99]. Moreover, lectins cannot differentiate between glycan 
AC
CE
PT
ED
 M
AN
US
CR
IPT
15 
 
subgroups, e.g., both N-linked and O-linked glycans possessing fucose residues bound by 
AAL. In addition, just a few lectins can be stained at a time on a tissue section due to possible 
steric hindrance of different glycan epitopes, which makes overall glycan imaging difficult. 
Another drawback of lectin based histostaining is quantification inaccuracy. Alternative 
imaging methods are being developed to obtain the required information from lectin stained 
assays [98]. Carbohydrate specific antibodies are more specific with respect to glycan 
recognition however, the number of currently available carbohydrate specific monoclonal 
antibodies is far from covering the entire palette of mammalian glycans.  
Utilizing the recent developments in MS technology, in one approach, mass spectrometry 
imaging (MSI) was utilized to acquire spatial information and molecular profiling of glycans 
from tissue sections [100]. Given the high specificity and sensitivity of mass spectrometry, 
MSI has addressed some of the handicaps of the common histostaining techniques. Prior 
knowledge of the glycans here is not essential, otherwise required for affinity-based 
immunohistochemistry staining. Moreover, hundreds of compounds can be detected in a 
single run, producing a vast amount of molecular information in a spatial manner. MSI can 
also support semi-quantitative and quantitative modes by sampling directly from the tissue 
sections. Albeit, advances of analytical techniques and data interpretation methodologies have 
extended the limits of glycomics studies [101], the low ionization efficiency of native glycans 
makes it difficult to study them from complex biological mixtures. Therefore, glycan analysis 
by mass spectrometry usually requires isolation, separation, extraction and chemical 
modification (e.g., permethylation) prior to analysis [102]. Using this approach, however, the 
spatial glycomic information is lost due to sample homogenization. Yang et al. [103] 
demonstrated that if glycans were released from solid phase immobilized glycoproteins, direct 
mass spectrometry analysis was applicable. This method did not require glycan purification to 
alleviate interferences from peptides and proteins representing a critical step during glycan 
imaging platform development to provide information about complex carbohydrates from 
samples with high biological complexity, like FFPE tissue specimens [98].  
Everest-Dass and Briggs [104] developed a novel method using MALDI MSI on formalin-
fixed paraffin-embedded tissue sections to search for tissue specific glycan markers. They 
investigated ovarian cancer tissue samples with porous graphitized carbon liquid 
chromatography connected to electrospray ionization mass spectrometry (PGC-LC-ESI-
MS/MS) and MALDI-MSI techniques to reveal structural glycan profile information. After 
the enzymatic release of N-glycans with peptide-N-glycanase, the sugars were separated by 
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porous graphitized carbon liquid chromatography (PGC-LC) and analyzed by collision 
induced electrospray MS fragmentation. The authors detected 40 individual N-glycan 
structures from the FFPE tissue section. The N-glycans found were high mannose, hybrid and 
complex (neutral and sialylated) type core fucosylated carbohydrates. The presence of these 
three generally known glycan structures was also verified by high-resolution MALDI-MS. 
Tissue-specific distribution of N-glycan structures detected in distinct regions of the tissue 
samples, i.e., high mannose glycans were mainly expressed in the tumor region, while 
complex or hybrid type N-glycans were abundant in the intervening stroma. Therefore, tumor 
and non-tumor tissue regions were clearly distinguished by their N-glycan structure 
allocations [104]. Powers et al. used MALDI imaging mass spectrometry and tissue 
microarrays to profile N-linked oligosaccharides from human and murine FFPE tissue 
samples and found 28 N-glycans in mouse kidney and another 13 in human pancreatic cancer 
FFPE tissues [78, 105]  
As there is a general interest to utilize the huge FFPE sample collection archives, novel, 
efficient and readily applicable glycan analysis methods should be developed. So far, LC/MS 
and MALDI techniques were mostly used for such investigations as described above. To the 
best of our knowledge, our group was the first to analyze glycan profiles from FFPE samples 
by capillary electrophoresis with high sensitivity laser induced fluorescence detection (CE-
LIF). We emphasize the global analysis aspect of the N-glycans from the FFPE tissue samples 
in contrast to the histological approach. To find possible formalin fixation mediated structural 
alterations at the glycome level, N-linked sugars of FFPE treated standard glycoproteins, as 
well as PNGase F released human serum and mouse tumor tissue sample glycans were 
analyzed. The liberated N-glycans were labeled by 8-aminopyrene-1,3,6-trisulfonic acid 
(APTS) fluorescent dye and separated by CE-LIF. The results revealed no apparent changes 
between the N-glycosylation patterns before and after the formalin fixation and paraffin 
embedding processes in all sample types examined. Thus, it was suggested that FFPE tissue 
samples could be readily utilized to discover disease related N-glycosylation changes at the 
molecular, cellular and tissue levels in prospective and retrospective studies [106]. 
3.4 Metabolomics and lipidomics 
Metabolomics is the global study of low molecular mass molecules (metabolites) found 
within biological systems [107]. Metabolites are precursors, intermediates or end products of 
biochemical processes, and information about the whole metabolic pathway represents 
additional information of the cellular state at a specific time point and represent the final level 
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of the omics cascade of genomics, transcriptomics, proteomics and glycomics [108]. 
Molecular pathways and interactions are generally studied through the analysis of metabolites 
[109]. However, additional factors, like the tumor microenvironment in case of cancers, may 
influence the metabolic profiles. Frequently observed polyclonality generates further 
hindrance to fully comprehend the metabolomic data. Metabolic profiling of intact tissue 
samples is becoming more popular in clinical research, as it can potentially identify novel 
prognostic or predictive metabolic biomarkers or explore the abnormal biochemical activity 
aiming to identify novel therapeutic targets [110]. 
Nuclear magnetic resonance (NMR) spectroscopy and MS or LC/MS are the most rapidly 
developing analytical techniques in the metabolomics field. NMR spectroscopy is usually 
used in the analysis of metabolic compounds that cannot be examined by GC/MS or LC/MS 
techniques. In high-throughput analysis of human liquid samples (e.g., blood), NMR is a very 
applicable method for quantitative and qualitative analysis of low-molecular-weight 
metabolites and lipids [111]. 
Lipids represent a significant part of the metabolome, so lipidomics research shares its main 
concepts and methods with the metabolomics field. For the time being, mass spectrometry is 
the dominant analytical technique in this field [112], and the two major MS-based approaches 
presently used are: 1) combined with separation techniques such as GC/MS or LC/MS, which 
are used for analyzing complex mixtures; and 2) shotgun approaches by which samples are 
directly transferred into the mass spectrometer. Hyphenation with LC is important in 
lipidomics because isomers could not be differentiated by MS alone. Recent biochemical 
studies have used deparaffinizing and lysing procedures for lipid analysis of FFPE samples. 
Gaudin et al. [113] assessed the reliability of FFPE human brain samples for lipidomic 
analysis. Their study demonstrated that isolating brain lipids from formalin fixed tissue 
samples was a feasible approach. 
As in other omics fields, metabolomics and lipidomics would greatly benefit from the ability 
to interrogate FFPE tissue specimens, acquired during routine medical examinations. Because 
of their widespread availability and long-term stability, accurate profiling of the metabolite 
content of these samples could accelerate the rate to discover clinically useful metabolomic 
biomarkers. Kelly et al. [107] were the first who described the analysis of polar metabolites 
from FFPE samples by LC/MS and found differences between malignant and non-malignant 
tissue samples based on more than a hundred molecules. Richter et al. used the same 
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analytical approach to assess the succinate / fumarate ratio in fresh frozen and FFPE samples 
[114] to reveal the effect of mutation in the succinate dehydrogenase gene (SDHx) in the 
sample. In other words, the succinate level increased, while fumarate decreased in the 
malignant state in individuals with SDHx mutation. Wojakowska et al. developed and 
validated a method to analyze primary metabolites from FFPE tissue samples using GC/MS 
technique and detected almost 70 compounds from the samples including even such sugars as 
glucose, galactose, erythrose and xylose [115]. 
4 Conclusion and future prospective 
Surgical tissue fixation by formaldehyde has unique advantages, e.g., simple fixation process 
and easy storage; however, alternative fixatives can be also useful in special cases such as 
preserving high-molecular weight DNA. FFPE samples represent a rich source for prospective 
and retrospective biomedical and biopharmaceutical studies. In comparison to fresh frozen 
samples, they have longer storage stability and simple storage conditions. Many reports have 
been recently published about extraction of nucleic acids, proteins, complex carbohydrates 
and metabolites/lipids from FFPE samples for biomarker discovery. DNA isolated from tissue 
FFPE blocks proved to be prudent material for the genomics field with PCR amplification and 
in microarray studies. Proteins isolated from FFPE specimens have been used in Western blot 
analysis and reverse-phase protein arrays, in spite of the fact that they are cross-linked during 
the formalin fixation process. Options to analyze the carbohydrate moieties of glycoproteins 
include liquid chromatography, capillary electrophoresis and mass spectrometry after sugar 
release and derivatization or by lectin arrays or imaging mass spectrometry in their intact 
form. Powerful metabolomics methods are based on magnetic resonance spectroscopy and 
mass spectrometry, the latter technique dominants in lipidomics also. MALDI imaging is also 
a recently emerging technique in metabolomics/lipidomics. Figure 3 summarizes the 
analytical techniques mentioned in this review. Since molecular level analysis of FFPE 
samples have long been a challenge in the omics field, specific protocols have been developed 
for the investigation of such tissue samples as critically discussed in this review. In all omics 
subfields, the first major challenge with FFPE tissue samples was to create appropriate 
archiving and testing methods for tissue samples. The next challenge will be to reveal the 
biological information from these samples and to use them in daily routine in clinical practice. 
To accomplish this mission, it is necessary to properly elaborate, apply and control/inspect the 
examination methods/analysis [116]. 
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With all the technological advances in the 21st century, we have a promising new opportunity 
to fully explore the biological information of FFPE specimens both in prospective and 
retrospective studies. Comprehensive analysis of this huge number of samples could reveal 
early diagnostic markers for a plethora of diseases including cancer and heart diseases, 
representing the Holy Grail for contemporary molecular diagnostics. 
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Figure legends 
Figure 1: Crosslinking of the polypeptide chains during formalin fixation. Adapted from [117] 
First step: the primary amine (nucleophilic group; R) forms a hydroxymethyl structure with 
the aldehyde. After losing a water molecule, a Schiff base is formed. Second step: a stable 
crosslink is produced between the proteins via methylene bridges.  
 
Figure 2: The formalin fixation and paraffin embedding process. i: sampling – it is usually 
done by a surgeon. ii: fixation – it takes place in a 10% buffered formalin solution for 24 to 48 
hours at room temperature. If samples are spaded, penetration of formalin into the tissue is 
more sufficient. iii: paraffin embedding – after dehydration of the sample by consecutive 
double washing with ethanol and xylene, it is embedded in melted paraffin and allowed to 
solidify at room temperature. iv: The block is then cut into 3-5 µm slices for pathologic and 
molecular diagnostic investigation. 
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Figure 3: Summary of the analytical techniques cited in this paper. CE: capillary 
electrophoresis; GC/MS: gas chromatography/ mass spectrometry; HPLC: high-performance 
liquid chromatography; LC/MS: liquid chromatography / mass spectrometry; MALDI: 
matrix-assisted laser desorption/ionization; MALDI FTICR IMS: matrix-assisted laser 
desorption/ionization Fourier transform ion cyclotron resonance imaging mass spectrometry; 
MS: mass spectrometry; MSI: mass spectrometry imaging; NMR: nuclear magnetic resonance 
spectroscopy; PGC-LC-ESI-MS/MS: porous graphitized carbon - liquid chromatography - 
electrospray ionization - tandem mass spectrometry; PCR: polymerase chain reaction; QRT-
PCR: quantitative reverse transcription - polymerase chain reaction; RPPA: reverse phase 
protein array; SELDI-TOF-MS: surface-enhanced laser desorption/ionization time-of-flight 
mass spectrometry. 
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Tables 
 
Table 1: The most frequently used fixatives for tissue preservation. 
Year of 
introduction 
Fixative Type of 
reaction 
Target References 
1893 Formalin Crosslink Protein, 
DNA  
 
[11] 
1908 Ethanol/Methanol 
 
Coagulation DNA [23, 24] 
1963 Glutaraldehyde Crosslink Nucleic 
acid/amino 
group 
[20, 21] 
1968 Carnoy’s fixative 
 
Coagulation RNA [25, 29] 
1970 Methacarn 
 
Coagulation RNA [28, 30] 
1970 Microwave 
irradiation(MW) 
Stabilization Protein [14] 
1992 AmeX Dehydration RNA, DNA [32] 
1994 Formalin + MW Crosslink+ 
Stabilization 
Protein [17] 
2000 Genipin  
 
Crosslink Amino acid [22] 
2001 HOPE  
 
Dehydration DNA, RNA [34] 
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